Neuropeptide Y receptor antagonists in obesity

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.12, 1997-12, pp. : 1827-1838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropeptide Y receptor antagonists

By Ling A.L.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 4, 1999-04 ,pp. : 375-384

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptide Y1 and Y5 Receptor Antagonists as Potential Anti-Obesity Drugs: Current Status

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 11, 2014-10 ,pp. : 896-919

Bentham Science Publishers

Access to resources Recommend Favorite

Recent developments with neuropeptide Y receptor antagonists

By Lundberg J.M. Modin A. Malmstrom R.E.

Trends in Pharmacological Sciences, Vol. 17, Iss. 9, 1996-09 ,pp. : 301-304

Elsevier

Access to resources Recommend Favorite

Pharmacology of neuropeptide Y receptor antagonists - Focus on cardiovascular functions

By Malmstrom R.E.

European Journal of Pharmacology, Vol. 447, Iss. 1, 2002-06 ,pp. : 11-30

Elsevier

Access to resources Recommend Favorite

GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y 1 receptor antagonists and neuropeptide Y Y 4 receptor agonists

By Parker E.M. Babij C.K. Balasubramaniam A. Burrier R.E. Guzzi M. Hamud F. Gitali Mukhopadhyay Rudinski M.S. Tao Z. Tice M. Xia L. Mullins D.E. Salisbury B.G.

European Journal of Pharmacology, Vol. 349, Iss. 1, 1998-05 ,pp. : 97-105

Elsevier

Access to resources Recommend Favorite